Two major pathways, RAF/MEK/ERK and PI3K/AKT/mTOR signaling, play critical roles in tumorigenesis of NSCLC [36, 37], and targeting these two pathways can lead to BCL-2 family-related apoptosis in NSCLC cells [38–41]. Here, MAP2K7 is linked to non-small cell lung carcinoma.